Trial sequential analysis of efficacy and safety outcomes after combination therapy of dexamethasone and anti-VEGF versus anti-VEGF monotherapy for DME.

<p>(A) Best-corrected visual acuity; (B) Incidence of increased intraocular pressure. Uppermost and lowermost red curves represent trial sequential monitoring boundary lines for benefit and harm, respectively. Inner red lines represent the futility boundary. Blue line represents evolution of c...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Bo Zhou (15092) (author)
مؤلفون آخرون:	Hua Liu (63708) (author), Feng Xiong (306053) (author)
منشور في:	2025
الموضوعات:	Biotechnology Immunology Cancer Science Policy Biological Sciences not elsewhere classified standard mean difference remains uncertain whether elevated intraocular pressure diabetic macular edema databases including pubmed corrected visual acuity central subfield thickness subgroup analysis suggests overall analysis revealed vegf versus anti vegf therapy showed triamcinolone plus anti dexamethasone plus anti show superior efficacy dme patients compared 2 </ sup vegfs ), corticosteroids vegf therapy rr ), vegf monotherapy vegf agents xlink "> tsa v0 therapeutic benefits systematic review study confirmed stata 12 rr 8 relevant studies r 4 q test prediction interval ocular hypertension numerous studies improving best greater reduction february 23 exhaustive search demonstrate superiority cons comprehensively confidence interval combined treatment combined results cochrane library clinical efficacy analyzed using 215 ). 208 ).
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Trial sequential analysis of efficacy and safety outcomes after combination therapy of dexamethasone and anti-VEGF versus anti-VEGF monotherapy for DME.

مواد مشابهة